NDC 0603-2553

Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate

Butalbital, Acetaminophen, Caffeine, And Codeine Phosphate

Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Par Pharmaceutical. The primary component is Butalbital; Acetaminophen; Caffeine; Codeine Phosphate.

Product ID0603-2553_19a12026-cf90-4644-9b09-7344c651d74e
NDC0603-2553
Product TypeHuman Prescription Drug
Proprietary NameButalbital, Acetaminophen, Caffeine, and Codeine Phosphate
Generic NameButalbital, Acetaminophen, Caffeine, And Codeine Phosphate
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2002-04-22
Marketing CategoryANDA / ANDA
Application NumberANDA075929
Labeler NamePar Pharmaceutical
Substance NameBUTALBITAL; ACETAMINOPHEN; CAFFEINE; CODEINE PHOSPHATE
Active Ingredient Strength50 mg/1; mg/1; mg/1; mg/1
Pharm ClassesBarbiturates [CS],Barbiturate [EPC],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE],Full Opioid Agonists [MoA],Opioid Agonist [EPC]
DEA ScheduleCIII
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0603-2553-21

100 CAPSULE in 1 BOTTLE, PLASTIC (0603-2553-21)
Marketing Start Date2002-04-22
Marketing End Date2022-09-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0603-2553-10 [00603255310]

Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate CAPSULE
Marketing CategoryANDA
Application NumberANDA075929
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2002-04-22
Marketing End Date2014-09-18

NDC 0603-2553-32 [00603255332]

Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate CAPSULE
Marketing CategoryANDA
Application NumberANDA075929
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2002-04-22
Marketing End Date2014-09-18

NDC 0603-2553-21 [00603255321]

Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate CAPSULE
Marketing CategoryANDA
Application NumberANDA075929
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2002-04-22

Drug Details

Active Ingredients

IngredientStrength
BUTALBITAL50 mg/1

OpenFDA Data

SPL SET ID:6f8cced0-4749-4a11-8f00-96d8c23c1cfd
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 993943
  • UPC Code
  • 0306032553218
  • Pharmacological Class

    • Barbiturates [CS]
    • Barbiturate [EPC]
    • Central Nervous System Stimulant [EPC]
    • Methylxanthine [EPC]
    • Xanthines [CS]
    • Central Nervous System Stimulation [PE]
    • Full Opioid Agonists [MoA]
    • Opioid Agonist [EPC]

    NDC Crossover Matching brand name "Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate" or generic name "Butalbital, Acetaminophen, Caffeine, And Codeine Phosphate"

    NDCBrand NameGeneric Name
    0591-2641Butalbital, Acetaminophen, Caffeine, and Codeine PhosphateButalbital, Acetaminophen, Caffeine, and Codeine Phosphate
    0591-3220Butalbital, Acetaminophen, Caffeine, and Codeine PhosphateButalbital, Acetaminophen, Caffeine, and Codeine Phosphate
    0603-2553Butalbital, Acetaminophen, Caffeine, and Codeine PhosphateButalbital, Acetaminophen, Caffeine, and Codeine Phosphate
    0722-6670Butalbital, Acetaminophen, Caffeine, and Codeine PhosphateButalbital, Acetaminophen, Caffeine, and Codeine Phosphate
    0722-7028Butalbital, Acetaminophen, Caffeine, and Codeine PhosphateButalbital, Acetaminophen, Caffeine, and Codeine Phosphate
    63629-3152Butalbital, Acetaminophen, Caffeine, and Codeine PhosphateButalbital, Acetaminophen, Caffeine, and Codeine Phosphate
    71335-0653Butalbital, Acetaminophen, Caffeine, and Codeine PhosphateButalbital, Acetaminophen, Caffeine, and Codeine Phosphate
    79739-6670Butalbital, Acetaminophen, Caffeine, and Codeine PhosphateButalbital, Acetaminophen, Caffeine, and Codeine Phosphate
    79739-7028Butalbital, Acetaminophen, Caffeine, and Codeine PhosphateButalbital, Acetaminophen, Caffeine, and Codeine Phosphate
    52544-082Fioricet with CodeineButalbital, Acetaminophen, Caffeine, and Codeine Phosphate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.